Quality of life after pulmonary metastasectomy
Recruiting
- Conditions
- C78.0Secondary malignant neoplasm of lung
- Registration Number
- DRKS00021113
- Lead Sponsor
- niversitätsklinikum Freiburg Klinik für Thoraxchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
1. Patients who underwent or will undergo pulmonary metastasectomy in curative intent
2. Treated at the Dept. for Thoracic Surgery from January 2013 – December 2021
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life (determined by questionnaire)
- Secondary Outcome Measures
Name Time Method perioperative factors influencing QoL, time without systemic treatment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the long-term quality of life outcomes for patients undergoing pulmonary metastasectomy for C78.0 secondary lung malignancies?
How does pulmonary metastasectomy compare to systemic therapy in improving survival and quality of life for secondary lung cancer patients?
Which biomarkers correlate with enhanced quality of life post-pulmonary metastasectomy in metastatic lung neoplasms?
What are the most common postoperative complications after pulmonary metastasectomy and their impact on patient-reported outcomes?
What role do tumor histology and metastatic burden play in quality of life outcomes following surgical resection of secondary lung tumors?